These outcomes, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the principle of focusing on ACKR3 as a novel approach to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Ailments. Sometimes I get a slight https://georgeg284asi9.dgbloggers.com/profile